Soleus Capital Management

Soleus Capital Management does not publicly list its CIO or managing principals. The firm's website and public filings do not name a single decision-maker, though its healthcare focus suggests a team with deep sector expertise.

Soleus invests across the healthcare spectrum, from public equities to private credit and co-investments. The firm appears to target both public company long/short positions and private deals, including debt instruments and growth-stage equity.

Soleus Capital Management primarily manages a healthcare-dedicated hedge fund that makes direct investments in public equities and private companies. There is no evidence of the firm committing to third-party funds as a limited partner.

Soleus is a healthcare-only firm, meaning it explicitly avoids sectors outside life sciences, biotech, medical devices, healthcare services, and related areas. No public statements specify other exclusions.

Soleus sources investments through its internal fundamental research team, focusing on regulatory and clinical catalysts in healthcare. The firm likely leverages relationships with management teams, investment banks, and healthcare consultants.

Soleus Capital Management operates as a hedge fund asset manager, not a single-family office. It manages capital for multiple external investors and maintains a traditional fund structure with management and performance fees.

Soleus does not disclose its investor base. The firm likely manages capital from institutional investors, endowments, foundations, and high-net-worth individuals, but no specific family or endowment is publicly named as an anchor investor.